These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12747773)

  • 1. Understanding the structure-activity relationship of the human ether-a-go-go-related gene cardiac K+ channel. A model for bad behavior.
    Pearlstein R; Vaz R; Rampe D
    J Med Chem; 2003 May; 46(11):2017-22. PubMed ID: 12747773
    [No Abstract]   [Full Text] [Related]  

  • 2. QT interval prolongation and cardiac risk assessment for novel drugs.
    Picard S; Lacroix P
    Curr Opin Investig Drugs; 2003 Mar; 4(3):303-8. PubMed ID: 12735231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management.
    Anderson ME; Al-Khatib SM; Roden DM; Califf RM;
    Am Heart J; 2002 Nov; 144(5):769-81. PubMed ID: 12422144
    [No Abstract]   [Full Text] [Related]  

  • 4. [Electropharmacological assessment of the risk of drug-induced long-QT syndrome using native cardiac cells and cultured cells expressing HERG channels].
    Nakaya H
    Nihon Yakurigaku Zasshi; 2003 Jun; 121(6):384-92. PubMed ID: 12835532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Etiological mechanism of long QT syndrome and the effects of macrolides].
    Kato T
    Jpn J Antibiot; 2001 Feb; 54 Suppl A():118-22. PubMed ID: 11439888
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessing the cardiac safety of ebastine. Epilogue.
    Roberts DJ
    Drug Saf; 1999; 21 Suppl 1():89-92. PubMed ID: 10597871
    [No Abstract]   [Full Text] [Related]  

  • 7. Ion channels: structure of a molecular brake.
    Sansom MS
    Curr Biol; 1999 Mar; 9(5):R173-5. PubMed ID: 10074448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More on the history of arrhythmia in long QT syndrome.
    Csanády M
    J Am Coll Cardiol; 2004 Sep; 44(6):1339; author reply 1339. PubMed ID: 15364343
    [No Abstract]   [Full Text] [Related]  

  • 9. [Genetic background predisposing the drug-induced long QT syndrome].
    Horie M
    Nihon Yakurigaku Zasshi; 2003 Jun; 121(6):401-7. PubMed ID: 12835534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital and acquired long QT syndrome.
    Camm AJ; Janse MJ; Roden DM; Rosen MR; Cinca J; Cobbe SM
    Eur Heart J; 2000 Aug; 21(15):1232-7. PubMed ID: 10924312
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular diagnosis and treatment of cardiovascular diseases.
    Duff HJ
    Can J Cardiol; 2000 Mar; 16(3):304-6. PubMed ID: 10744791
    [No Abstract]   [Full Text] [Related]  

  • 12. Allelic variants in long-QT disease genes in patients with drug-associated torsades de pointes.
    Yang P; Kanki H; Drolet B; Yang T; Wei J; Viswanathan PC; Hohnloser SH; Shimizu W; Schwartz PJ; Stanton M; Murray KT; Norris K; George AL; Roden DM
    Circulation; 2002 Apr; 105(16):1943-8. PubMed ID: 11997281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Famotidine does not induce long QT syndrome: experimental evidence from in vitro and in vivo test systems.
    Sugiyama A; Satoh Y; Takahara A; Nakamura Y; Shimizu-Sasamata M; Sato S; Miyata K; Hashimoto K
    Eur J Pharmacol; 2003 Apr; 466(1-2):137-46. PubMed ID: 12679150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular genetics of the long QT syndrome: genes causing fainting and sudden death.
    Vincent GM
    Annu Rev Med; 1998; 49():263-74. PubMed ID: 9509262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotropic drugs, HERG, and the heart.
    Hancox JC; Witchel HJ
    Lancet; 2000 Jul; 356(9227):428. PubMed ID: 10972395
    [No Abstract]   [Full Text] [Related]  

  • 16. The inherited long QT syndrome: from ion channel to bedside.
    Vincent GM; Timothy K; Fox J; Zhang L
    Cardiol Rev; 1999; 7(1):44-55. PubMed ID: 10348966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of pro-arrhythmic risk of drugs due to QT interval prolongation by the HERG expression system].
    Chachin M; Kurachi Y
    Nihon Yakurigaku Zasshi; 2002 Jun; 119(6):345-51. PubMed ID: 12089906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New missense mutation (G626V) in the predicted selectivity filter of the HERG channel associated with familial long QT syndrome.
    Jahr S; Lewalter T; Hesch RD; Lüderitz B; Englisch S
    Hum Mutat; 2000 Jun; 15(6):584. PubMed ID: 10862104
    [No Abstract]   [Full Text] [Related]  

  • 19. HERG K+ channels: friend and foe.
    Vandenberg JI; Walker BD; Campbell TJ
    Trends Pharmacol Sci; 2001 May; 22(5):240-6. PubMed ID: 11339975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long QT syndrome.
    Priori SG; Bloise R; Crotti L
    Europace; 2001 Jan; 3(1):16-27. PubMed ID: 11271945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.